Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics

American Journal of Ophthalmology

Volumn 131, Issue 1, 2001, Pages 19-24

  Brubaker, Richard F ^a   Schoff, Erik O ^a   Nau, Cherie B ^a   Carpenter, Susan P ^b   Chen, Kuankuan ^b   Vandenburgh, Amanda M ^b  

^a MAYO CLINIC   (United States)

^b ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BIMATOPROST; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AQUEOUS HUMOR FLOW; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FLUOROPHOTOMETRY; GLAUCOMA; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TONOMETER; VOLUNTEER;

ADULT; AMIDES; ANTIHYPERTENSIVE AGENTS; AQUEOUS HUMOR; CIRCADIAN RHYTHM; DOUBLE-BLIND METHOD; FEMALE; FLUOROPHOTOMETRY; HUMANS; INTRAOCULAR PRESSURE; LIPIDS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; TONOMETRY, OCULAR;

EID: 0035163062     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00843-6     Document Type: Article

References (12)

1. 2α with a hydroxyl or methoxy substituent provides biologically unique compounds. Br J Pharmacol 2000;130:1933-1943.
2. 2α) 1-ethanolamide: a pharmacologically unique local hormone synthesized from anandamide [abstract 17]. 11th International Conference on Advances in Prostaglandin and Leukotriene Research, Florence, Italy, June 4 -8, 2000.
3. 2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 1997;272:21181-21186.
4. VanDenburgh AM, Laibovitz R A, Felix C. A novel ocular hypotensive lipid: initial safety and efficacy of AGN 192024. Invest Ophthalmol Vis Sci 1998:39:3258.
5. Brubaker RF. Clinical measurements of aqueous dynamics: implications for addressing glaucoma. In: Civan M, editor. Current topics in membranes. The eye's aqueous humor. San Diego: Academic Press, 1998;45:233-284.
6. Chandler PA, Grant WM. Glaucoma. Philadelphia: Lea & Febiger, 1979:20.
7. Maus TL, Nau C, Brubaker RF. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents. Arch Ophthalmol 1999;117:586-591.
8. Maus TL, McLaren JW, Shepard JW Jr, Brubaker RF. The effects of sleep on circulating catecholamines and aqueous flow in human subjects. Exp Eye Res 1996;62:351-358.
9. Larsson L-I, Pach JM, Brubaker RF. Aqueous humor dynamics in patients with diabetes mellitus. Am J Ophthalmol 1995;120:362-367.
10. Bárány EH. A mathematical formulation of intraocular pressure as dependent on secretion, ultrafiltration, bulk outflow, and osmotic absorption of fluid. Invest Ophthalmol 1963;2:584-590.
11. Bill A. Blood circulation and fluid dynamics in the eye. Physiol Rev 1975;55:383-417.
12. Goldmann H. Abflussdruck, Minutenvolumen, und Widerstand der Kammerwasserströmung des Menschen. Doc Ophthal 1951;5-6:278-356.